{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:09:50Z","timestamp":1785305390527,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03081-1","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:02:29Z","timestamp":1710493349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical profile and challenges faced in the management of optic neuritis: the Indian scenario"],"prefix":"10.1007","volume":"44","author":[{"given":"Madhurima","family":"Kaushik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6899-6690","authenticated-orcid":false,"given":"Virna Mahesh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik Kumar","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriram","family":"Vardharajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"3081_CR1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112. https:\/\/doi.org\/10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"key":"3081_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89. https:\/\/doi.org\/10.1212\/NXI.0000000000000089","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3081_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","volume":"111","author":"RW Beck","year":"1993","unstructured":"Beck RW, Cleary PA (1993) Optic neuritis treatment trial: one-year follow-up results. Arch Ophthalmol 111:773\u2013775. https:\/\/doi.org\/10.1001\/archopht.1993.01090060061023","journal-title":"Arch Ophthalmol"},{"key":"3081_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/0301-4738.121131","volume":"62","author":"R Saxena","year":"2014","unstructured":"Saxena R, Phuljhele S, Menon V, Gadaginamath S, Sinha A, Sharma P (2014) Clinical profile and short-term outcomes of optic neuritis patients in India. Indian J Ophthalmol 62:265\u2013267. https:\/\/doi.org\/10.4103\/0301-4738.121131","journal-title":"Indian J Ophthalmol"},{"key":"3081_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/0028-3886.103186","volume":"60","author":"L Pandit","year":"2012","unstructured":"Pandit L, Shetty R, Misri Z et al (2012) Optic neuritis: experience from a south Indian demyelinating disease registry. Neurol India 60:470\u2013475. https:\/\/doi.org\/10.4103\/0028-3886.103186","journal-title":"Neurol India"},{"issue":"1","key":"3081_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/ijo.IJO_887_21","volume":"70","author":"S Ambika","year":"2022","unstructured":"Ambika S, Durgapriyadarshini S, Padmalakshmi K, Noronha V, Arjundas D (2022) Clinical profile, imaging features and short-term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica. Indian J Ophthalmol 70(1):194\u2013200. https:\/\/doi.org\/10.4103\/ijo.IJO_887_21","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"3081_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00417-015-3191-z","volume":"254","author":"DP Lyttle","year":"2016","unstructured":"Lyttle DP, Johnson LN, Margolin EA, Madsen RW (2016) Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 254(4):757\u2013764. https:\/\/doi.org\/10.1007\/s00417-015-3191-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3081_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"issue":"11","key":"3081_CR9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS L\u00f3pez-Chiriboga","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Majed M, Fryer J et al (2018) Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol 75(11):1355\u20131363. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1814","journal-title":"JAMA Neurol"},{"issue":"2","key":"3081_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"3081_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1177\/1352458514521503","volume":"20","author":"L Pandit","year":"2014","unstructured":"Pandit L, Kundapur R (2014) Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India. Mult Scler 20:1651\u20131653. https:\/\/doi.org\/10.1177\/1352458514521503","journal-title":"Mult Scler"},{"key":"3081_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10792-015-0048-8","volume":"35","author":"S Ambika","year":"2015","unstructured":"Ambika S, Balasubramanian M, Theresa L, Veeraputhiran A, Arjundas D (2015) Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India. Int Ophthalmol 35:801\u2013806. https:\/\/doi.org\/10.1007\/s10792-015-0048-8","journal-title":"Int Ophthalmol"},{"issue":"3","key":"3081_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/0890334420970496","volume":"37","author":"J Jeslin","year":"2021","unstructured":"Jeslin J, Seetharaman C, Shah VM (2021) Optic neuritis during lactation: a case series. J Hum Lact 37(3):577\u2013580. https:\/\/doi.org\/10.1177\/0890334420970496","journal-title":"J Hum Lact"},{"key":"3081_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000112858","volume":"29","author":"LC Woung","year":"2007","unstructured":"Woung LC, Lin CH, Tsai CY, Tsai MT, Jou JR, Chou P (2007) Optic neuritis among national health insurance enrollees in Taiwan, 2000\u20132004. Neuroepidemiology 29:250\u2013254. https:\/\/doi.org\/10.1159\/000112858","journal-title":"Neuroepidemiology"},{"key":"3081_CR15","first-page":"667","volume":"49","author":"SA Lim","year":"2008","unstructured":"Lim SA, Goh KY, Tow S et al (2008) Optic neuritis in Singapore. Singapore Med J 49:667\u2013671","journal-title":"Singapore Med J"},{"key":"3081_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.540156","volume":"11","author":"AG Filippatou","year":"2020","unstructured":"Filippatou AG, Mukharesh L, Saidha S, Calabresi PA, Sotirchos ES (2020) AQP4-IgG and MOG-IgG related optic neuritis-prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis. Front Neurol 11:540156. https:\/\/doi.org\/10.3389\/fneur.2020.540156","journal-title":"Front Neurol"},{"issue":"10","key":"3081_CR17","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","volume":"126","author":"H Ishikawa","year":"2019","unstructured":"Ishikawa H, Kezuka T, Shikishima K et al (2019) Epidemiologic and clinical characteristics of optic neuritis in Japan. Ophthalmology 126(10):1385\u20131398. https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.042","journal-title":"Ophthalmology"},{"key":"3081_CR18","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","volume":"125","author":"J Jitprapaikulsan","year":"2018","unstructured":"Jitprapaikulsan J, Chen JJ, Flanagan EP et al (2018) Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis. Ophthalmology 125:1628\u20131637. https:\/\/doi.org\/10.1016\/j.ophtha.2018.03.041","journal-title":"Ophthalmology"},{"key":"3081_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","volume":"220","author":"MB Hassan","year":"2020","unstructured":"Hassan MB, Stern C, Flanagan EP et al (2020) Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies. Am J Ophthalmol 220:110\u2013114. https:\/\/doi.org\/10.1016\/j.ajo.2020.07.014","journal-title":"Am J Ophthalmol"},{"key":"3081_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/1352458519845112","volume":"26","author":"CL de Mol","year":"2020","unstructured":"de Mol CL, Wong Y, van Pelt ED et al (2020) The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler 26:806\u2013814. https:\/\/doi.org\/10.1177\/1352458519845112","journal-title":"Mult Scler"},{"key":"3081_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","volume":"195","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, Flanagan EP, Jitprapaikulsan J et al (2018) Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol 195:8\u201315. https:\/\/doi.org\/10.1016\/j.ajo.2018.07.020","journal-title":"Am J Ophthalmol"},{"key":"3081_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1874364101812010247","volume":"12","author":"L Hansapinyo","year":"2018","unstructured":"Hansapinyo L, Vivattanaseth C (2018) Clinical characteristics, treatment outcomes and predictive factors in optic neuritis. Open Ophthalmol J 12:247\u2013255. https:\/\/doi.org\/10.2174\/1874364101812010247","journal-title":"Open Ophthalmol J"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03081-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03081-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03081-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:34:38Z","timestamp":1741880078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03081-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3081"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03081-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.\u00a0It was approved by the institutional ethics committee of Aravind Eye Hospital, Madurai, India (Ref. No. RET202100392 dated 23.6.2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors affirm that human research participants provided informed consent for the publication of the images in Figs.\u00a0, , and .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"138"}}